Recognized as a leader in AI-driven pathology solutions, Mindpeak is advancing cancer diagnostics with deep learning-powered tissue analysis technologies

Mindpeak GmbH, global innovator in AI-driven digital pathology, has been named to CBInsights’ prestigious Digital Health 50 list for 2024. This recognition highlights the world’s most promising digital health companies, selected from over 10,000 candidates based on their innovation, market potential, and industry impact.

“The 2024 Digital Health 50 cohort highlights high-momentum companies driving meaningful change across healthcare. This year’s winners are at the forefront of bringing an AI-driven infrastructure to healthcare, transforming diagnostics, and bringing condition-specific care platforms to patients and providers. These companies are accelerating the transformation of healthcare delivery, streamlining workflows, and advancing patient outcomes globally,”

said Amrit Panjabi, Intelligence Analyst at CB Insights. 

With its world-leading, clinical-grade AI solutions for pathology, Mindpeak is revolutionizing cancer diagnostics on a global scale. Its algorithms were among the first to be deployed for routine clinical diagnostics, solidifying the company’s leadership in the field. Integrated into more image management platforms than any competitor, its solutions enable seamless adoption and broad accessibility.  

“We are proud to have earned a place on CB Insights’ Digital Health 50 list. Our mission is to empower healthcare professionals by improving the accuracy and efficiency of pathological diagnosis. Through our AI-driven solutions, we support pathologists in enhancing diagnostic workflows, enabling faster and more precise results. This recognition reaffirms our commitment to advancing innovation in cancer care,”

said Felix Faber, Co-Founder and CEO of Mindpeak. 

About Mindpeak

Founded in 2018, Mindpeak is a global innovator in AI-driven digital pathology solutions. The company develops cutting-edge algorithms that support pathologists in routine diagnostics, focusing on automating tissue analysis for faster, more accurate results. Mindpeak’s platform is designed to enhance productivity and diagnostic confidence in clinical labs, helping to improve patient outcomes in cancer care.